<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="172">
  <stage>Registered</stage>
  <submitdate>10/08/2005</submitdate>
  <approvaldate>15/08/2005</approvaldate>
  <actrnumber>ACTRN12605000147684</actrnumber>
  <trial_identification>
    <studytitle>The DRIP Trial</studytitle>
    <scientifictitle>A randomised phase III study to evaluate the effects of changing peripheral intravenous cannulas when clinically indicated to reduce the rate of cannula related complications</scientifictitle>
    <utrn />
    <trialacronym>The DRIP Trial</trialacronym>
    <secondaryid>wigan1943@bigpond.com</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Phlebitis and other adverse outcomes of peripheral venous cannulation.</healthcondition>
    <conditioncode>
      <conditioncode1>Inflammatory and Immune System</conditioncode1>
      <conditioncode2>Rheumatoid arthritis</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Intervention: Cannula re-sited when clinically indicated</interventions>
    <comparator>Control: Cannula re-sited every 3 days</comparator>
    <control>Dose comparison</control>
    <interventioncode>Treatment: Devices</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>I/V related morbidity (using a composite measure of any reason for unplanned cannula removal)</outcome>
      <timepoint>Catheter removal</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Cost</outcome>
      <timepoint>At completion of trial</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>1. they are inpatients at the Royal Brisbane and Women's Hospital. 2. They are scheduled or expected to have a peripheral venous catheter indwelling for at least 4 days.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>Not stated</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>1. Patients with an existing bloodstream infection 2. Those receiving immunosupressive treatment.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Central telephone</concealment>
    <sequence>Computer generated</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 2 / Phase 3</phase>
    <anticipatedstartdate>22/02/2006</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>754</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Joan Webster</primarysponsorname>
    <primarysponsoraddress>RBWH
Butterfield St 
Herston QLD 4029</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>Queensland Nursing Council</fundingname>
      <fundingaddress>No longer exists</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>None</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Most hospitals re-site peripheral intravenous catheters in adults every 72-96 hours, based on current Centers of Disease Control and Prevention Guidelines. This is at odds with regimes for children, and critically ill patients, where cannulas are only re-sited when clinically indicated. Recent prospective surveillance studies have demonstrated the safety of longer dwell times but these observations have not been validated in adults, using randomised controlled trial methodology.
The primary aim of the present study is to compare the rates of peripheral catheter-related local infection, phlebitis and obstruction between two groups of patients - those having routine catheter changes every 72 hours and those having catheter changes only when clinically indicated.</summary>
    <trialwebsite />
    <publication>Webster J, Clarke S, Paterson D, Hutton A, Van Dyk S, Gale C, Hopkins T. Peripheral intravenous catheters: randomized controlled trial of elective versus clinically indicated replacement. BMJ. 2008 Jul 8;337:a339. doi: 10.1136/bmj.a339</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Royal Brisbane and Women's Hospital</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Joan Webster</name>
      <address>Teaching and Research
Royal Brisbane and Women's Hospital
Level 6
Ned Hanlon Building
Herston QLD 4029</address>
      <phone>+61 7 36368590</phone>
      <fax>+61 7 36362123</fax>
      <email>joan_webster@health.qld.gov.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Joan Webster</name>
      <address>Teaching and Research
Royal Brisbane and Women's Hospital
Level 6
Ned Hanlon Building
Herston QLD 4029</address>
      <phone>+61 7 36368590</phone>
      <fax>+61 7 36362123</fax>
      <email>joan_webster@health.qld.gov.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>